CVR Medical Corp V.CVM.H

Alternate Symbol(s): CRRVF

Healthcare Medical Devices

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool, which complements other stroke screening technology such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA) and computed tomography angiography (CTA). The CSS is non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers.

TSXV:CVM.H - Post by User

CVR Medical Corp

Bullboard Posts

Comment by Aquaman11on Dec 29, 2018 1:12pm

48 Views

Post# 29168014

RE:RE:RE:Just for Fun

Growth100Percnt wrote: It all depends on how many more shares are issued but I have to agree with Abovenbeyond.

Once we start seeing revenues and depending on what management plans to do with the profits (eg. more research for future devices maybe? ) it could reach $2 -$3 eventually.

Agree...

If you look at P.32 of this earlier document: https://cvrmed.com/wp-content/uploads/2018/07/CVR_MEDICAL-Executive-Informational-Overview-07-23-18.pdf

"If" this gets FDA approval (always a risk), take $32M sales of first year (the conservative scenario), bring the number of shares at 100M (further dilution) and bring this to a P/E of 10, should be $3 at some point in near future ...the real interesting numbers would be three years down the line according to the same projection.

Bullboard Posts

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles